{'fraction_non_alphanumeric': 0.02023608768971332, 'fraction_numerical': 0.0016863406408094434, 'mean_word_length': 5.674157303370786, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of a gastro‐protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: A double‐blind placebo‐controlled study in Japan

Background and Aim:  Although mucosal protective agents have been used frequently for treatment of symptomatic gastritis, there has been no well‐controlled study of functional dyspepsia. The aim of this study was to assess the efficacy of a 4‐week treatment with rebamipide for the relief of overall dyspeptic symptoms and the improvement in quality of life from an untreated baseline in Japanese patients with functional dyspepsia.